DNA methylation in stem cell renewal and multipotency

dc.contributor.authorBerdasco, María
dc.contributor.authorEsteller, Manel
dc.date.accessioned2018-09-10T07:12:55Z
dc.date.available2018-09-10T07:12:55Z
dc.date.issued2011-10-31
dc.date.updated2018-07-24T12:58:40Z
dc.description.abstractOwing to their potential for differentiation into multiple cell types, multipotent stem cells extracted from many adult tissues are an attractive stem cell resource for the replacement of damaged tissues in regenerative medicine. The requirements for cellular differentiation of an adult stem cell are a loss of proliferation potential and a gain of cell-type identity. These processes could be restricted by epigenetic modifications that prevent the risks of lineage-unrelated gene expression or the undifferentiated features of stem cells in adult somatic cells. In this review, we focus on the role of DNA methylation in controlling the transcriptional activity of genes important for self-renewal, the dynamism of CpG methylation of tissue-specific genes during several differentiation programs, and whether the multilineage potential of adult stem cells could be imposed early in the original precursor stem cells through CpG methylation. Additionally, we draw attention to the role of DNA methylation in adult stem cell differentiation by reviewing the reports on spontaneous differentiation after treatment with demethylating agents and by considering the evidence provided by reprogramming of somatic cells into undifferentiated cells (that is, somatic nuclear transfer or generation of induced pluripotent cells). It is clear from the evidence that DNA methylation is necessary for controlling stem cell proliferation and differentiation, but their exact contribution in each lineage program is still unclear. As a consequence, in a clinical setting, caution should be exerted before employing adult stem cells or their derivatives in regenerative medicine and appropriate tests should be applied to ensure the integrity of the genome and epigenome.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid22041459
dc.identifier.urihttps://hdl.handle.net/2445/124382
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/scrt83
dc.relation.ispartofStem Cell Research & Therapy, 2011, vol. 2, num. 42
dc.relation.urihttps://doi.org/10.1186/scrt83
dc.rightscc by (c) Berdasco, María; Esteller, Manel, 2011
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationADN
dc.subject.classificationCèl·lules mare
dc.subject.classificationMedicina regenerativa
dc.subject.otherDNA
dc.subject.otherStem cells
dc.subject.otherRegenerative medicine
dc.titleDNA methylation in stem cell renewal and multipotency
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
BerdascoM.pdf
Mida:
805.88 KB
Format:
Adobe Portable Document Format